The chemical class termed Vmn2r11 Inhibitors encompasses a diverse array of compounds that, while not directly inhibiting Vmn2r11, affect various signaling pathways and cellular processes that could indirectly modulate the activity or signal transduction of Vmn2r11. These chemicals work through different mechanisms, such as modulation of cAMP levels, inhibition of kinase activity, alteration of calcium signaling, and interference with phospholipase C or PI3K/AKT signaling pathways. Their actions on these pathways suggest a broad strategy for influencing the cellular context in which Vmn2r11 operates, rather than targeting the protein directly. This approach reflects an understanding of cellular signaling as a network of interconnected pathways, where modulation of one node can ripple through the network to affect various components, including those like Vmn2r11, which are involved in specific sensory signaling processes.
Each chemical listed plays a role in the intricate dance of cellular signaling, acting at different points to modulate the flow of information through the cell. For instance, compounds that increase intracellular cAMP levels or inhibit specific kinases can alter the broader signaling landscape, creating conditions that either promote or inhibit the function of proteins related to Vmn2r11. By affecting the signaling pathways that Vmn2r11 is part of or relies on for its function, these chemicals offer a means to indirectly influence its activity. This approach to modulation does not rely on direct interaction with the Vmn2r11 protein but instead alters the cellular environment and the constellation of signals that regulate its activity. Through such indirect means, it is possible to influence the function of Vmn2r11 and related signaling pathways, providing insight into the complex regulatory mechanisms that govern cellular response to external and internal stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
Inhibits RAF kinase, which is part of the MAPK/ERK pathway, indirectly affecting signal transduction processes Vmn2r11 might be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, affecting AKT signaling and potentially altering GPCR-mediated pathways that could intersect with Vmn2r11's function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, affecting GPCR downstream signaling, which may indirectly influence Vmn2r11 signal transduction. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is upstream of ERK in the MAPK pathway, potentially affecting signaling pathways that Vmn2r11 may participate in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, affecting stress response and cytokine signaling in a manner that could indirectly influence Vmn2r11's signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, modulating apoptosis and inflammation signaling pathways that might intersect with Vmn2r11's function in cellular signaling. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular calcium, affecting calcium-mediated signaling pathways and potentially altering Vmn2r11's activity in calcium-dependent processes. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
Inhibits protein kinase A (PKA), potentially affecting cAMP-mediated GPCR signaling pathways, including those related to Vmn2r11. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, potentially affecting signaling pathways that intersect with GPCR-mediated processes, indirectly influencing Vmn2r11. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Inhibits calmodulin, affecting calcium signal transduction and potentially influencing pathways related to Vmn2r11's function. | ||||||